Cleared Traditional

MediLab (K221065) - FDA 510(k) Clearance

Class II Radiology device cleared through predicate-based substantial equivalence - typically does not require clinical trials.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
59d
Days
Class 2
Risk

K221065 is an FDA 510(k) clearance for the MediLab. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Sigma Scientific Services, LLC (Tamarac, US). The FDA issued a Cleared decision on June 10, 2022 after a review of 59 days - a notably fast clearance cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Sigma Scientific Services, LLC devices

Submission Details

510(k) Number K221065 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2022
Decision Date June 10, 2022
Days to Decision 59 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
48d faster than avg
Panel avg: 107d · This submission: 59d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 802
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K221065.
Syngo Carbon Space VA20A
K213665 · Siemens Healthcare GmbH · Jun 2022
ElucidVivo A.3
K221463 · Elucid Bioimaging, Inc. · Jun 2022
SurgiCase Viewer
K213684 · Materialise NV · Jun 2022
3D Anatomic Models
K220205 · Ricoh USA, Inc. · Jun 2022
EchoNavigator R4.0
K221270 · Philips Medical Systems Nederland B.V. · May 2022
SwiftMR
K220416 · Airs Medical, Inc. · May 2022